The DOI matches its Crossref record; 143 of the 145 references it cites were found in a registry or an index.
Case Detection, Diagnosis, and Treatment of Patients with Primary Aldosteronism: An Endocrine Society Clinical Practice Guideline
Open accessAbstract
OBJECTIVE: Our objective was to develop clinical practice guidelines for the diagnosis and treatment of patients with primary aldosteronism. PARTICIPANTS: The Task Force comprised a chair, selected by the Clinical Guidelines Subcommittee (CGS) of The Endocrine Society, six additional experts, one methodologist, and a medical writer. The Task Force received no corporate funding or remuneration. EVIDENCE: Systematic reviews of available evidence were used to formulate the key treatment and prevention recommendations. We used the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) group criteria to describe both the quality of evidence and the strength of recommendations. We used "recommend" for strong recommendations and "suggest" for weak recommendations. CONSENSUS PROCESS: Consensus was guided by systematic reviews of evidence and discussions during one group meeting, several conference calls, and multiple e-mail communications. The drafts prepared by the task force with the help of a medical writer were reviewed successively by The Endocrine Society's CGS, Clinical Affairs Core Committee (CACC), and Council. The version approved by the CGS and CACC was placed on The Endocrine Society's Web site for comments by members. At each stage of review, the Task Force received written comments and incorporated needed changes. CONCLUSIONS: We recommend case detection of primary aldosteronism be sought in higher risk groups of hypertensive patients and those with hypokalemia by determining the aldosterone-renin ratio under standard conditions and that the condition be confirmed/excluded by one of four commonly used confirmatory tests. We recommend that all patients with primary aldosteronism undergo adrenal computed tomography as the initial study in subtype testing and to exclude adrenocortical carcinoma. We recommend the presence of a unilateral form of primary aldosteronism should be established/excluded by bilateral adrenal venous sampling by an experienced radiologist and, where present, optimally treated by laparoscopic adrenalectomy. We recommend that patients with bilateral adrenal hyperplasia, or those unsuitable for surgery, optimally be treated medically by mineralocorticoid receptor antagonists.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Mineralocorticoid excess can be caused by either bilateral hyperplasia or ACA, and these lesions are usually small (<2 cm) (115).”
From Adrenocortical carcinoma (2014) · cites this paper as [115]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Grading quality of evidence and strength of recommendations
(2004) · BMJ · doi:10.1136/bmj.328.7454.1490 · Cited by 8,477
Pitt, B., Remme, W., Zannad, F., Neaton, J., Martinez, F., Roniker, B., Bittman, R., Hurley, S., Kleiman, J., & Gatlin, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030207 · Cited by 4,941
Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism
Milliez, P., Girerd, X. J., Plouin, P., Blacher, J., Safar, M. E., & Mourad, J. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.01.015 · Cited by 1,541
A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients
Rossi, G. P., Bernini, G., Caliumi, C., Desideri, G., Fabris, B., Ferri, C., Ganzaroli, C., Giacchetti, G., Letizia, C., Maccario, M., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.07.059 · Cited by 1,467
Self-citationLifton, R. P., Dluhy, R. G., Powers, M., Rich, G. M., Cook, S., Ulick, S., & Lalouel, J.-M. (1992) · Nature · doi:10.1038/355262a0 · Cited by 1,158
The Incidentally Discovered Adrenal Mass
Young, W. F. (2007) · New England Journal of Medicine · doi:10.1056/nejmcp065470 · Cited by 1,090
Self-citationMulatero (2004) · doi:10.1210/jc.2003-031337 · Cited by 961
Self-citationA Survey on Adrenal Incidentaloma in Italy
Mantero, F. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.2.637 · Cited by 907
Self-citationIncidentally Discovered Adrenal Masses*
Kloos, R. T., Gross, M. D., Francis, I. R., KOROBKIN, M. T., & Shapiro, B. (1995) · Endocrine Reviews · doi:10.1210/edrv-16-4-460 · Cited by 869
Hyperaldosteronism Among Black and White Subjects With Resistant Hypertension
Calhoun, D. A., Nishizaka, M. K., Zaman, M. A., Thakkar, R. B., & Weissmann, P. (2002) · Hypertension · doi:10.1161/01.hyp.0000040261.30455.b6 · Cited by 763
Research works printed but not linked: 1
- Ganguly, 1976, Spironolactone therapy in primary aldosteronism: diagnostic and therapeutic implications, In: Sambhi MP, ed. Systemic effects of antihypertensive agents. New York: Stratton;, 383
Cited by
Sorted by citations
Items 201–300 of 1,000
Apostolopoulou, K., Kunzel, H. E., Gerum, S., Merkle, K., Schulz, S., Fischer, E., Pallauf, A., Brand, V., Bidlingmaier, M., Endres, S., et al. (2012) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2012.665480 · Cited by 73
Purinergic Inhibition of ENaC Produces Aldosterone Escape
Stockand, J. D., Mironova, E., Bugaj, V., Rieg, T., Insel, P. A., Vallon, V., Peti‐Peterdi, J., & Pochynyuk, O. M. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010040377 · Cited by 70
Marzano, L. A., Colussi, G., Sechi, L. A., & Catena, C. (2014) · American Journal of Hypertension · doi:10.1093/ajh/hpu154 · Cited by 73
Hong, A. R., Kim, J. H., Park, K. S., Kim, K. Y., Lee, J. H., Kong, S. H., Lee, S. Y., Shin, C. S., Kim, S. W., & Kim, S. Y. (2017) · European Journal of Endocrinology · doi:10.1530/eje-17-0372 · Cited by 75
Hinchliffe, E., Carter, S., Owen, L. J., & Keevil, B. G. (2012) · Journal of Chromatography B · doi:10.1016/j.jchromb.2012.11.013 · Cited by 72
Manolopoulou, J., Fischer, E., Dietz, A., Diederich, S., Holmes, D. T., Junnila, R. K., Grimminger, P., Reincke, M., Morganti, A., & Bidlingmaier, M. (2015) · Journal of Hypertension · doi:10.1097/hjh.0000000000000727 · Cited by 72
Reversible Sympathetic Overactivity in Hypertensive Patients with Primary Aldosteronism
Kontak, A. C., Wang, Z., Arbique, D., Adams-Huet, B., Auchus, R. J., Nesbitt, S. D., Victor, R. G., & Vongpatanasin, W. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0823 · Cited by 71
Primary Aldosteronism: Where Are We Now? Where to From Here?
Funder, J. W., & Carey, R. M. (2022) · Hypertension · doi:10.1161/hypertensionaha.121.18761 · Cited by 71
Self-citationHigh prevalence of autonomous aldosterone secretion among patients with essential hypertension
Gouli, A., Kaltsas, G., Τζώνου, Α., Markou, Α., Androulakis, I. I., Ragkou, D., Vamvakidis, K., Zografos, G., Kontogeorgos, G., Chrousos, G. P., et al. (2011) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2011.02531.x · Cited by 71
Ray, J. A., Kushnir, M. M., Palmer, J., Sadjadi, S., Rockwood, A. L., & Meikle, A. W. (2014) · Journal of Chromatography B · doi:10.1016/j.jchromb.2014.08.042 · Cited by 71
Intra-adrenal Aldosterone Secretion: Segmental Adrenal Venous Sampling for Localization
Satani, N., Ota, H., Seiji, K., Morimoto, R., Kudo, M., Iwakura, Y., Ono, Y., Nezu, M., Omata, K., Ito, S., et al. (2015) · Radiology · doi:10.1148/radiol.2015142159 · Cited by 71
Monticone, S., Satoh, F., Viola, A., Fischer, E., Vonend, O., Bernini, G. P., Lucatello, B. G., Quinkler, M. O., Ronconi, V., Morimoto, R., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2345 · Cited by 70
Nakajima, Y., Yamada, M., Taguchi, R., Satoh, T., Hashimoto, K., Ozawa, A., Shibusawa, N., Okada, S., Monden, T., & Mori, M. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2743 · Cited by 70
Test characteristics of the aldosterone-to-renin ratio as a screening test for primary aldosteronism
Jansen, P. M., van den Born, B. H., Frenkel, W. J., de Bruijne, E. L. E., Deinum, J., Kerstens, M. N., Smulders, Y. M., Woittiez, A. J. J., Wijbenga, J. A. M., Zietse, R., et al. (2013) · Journal of Hypertension · doi:10.1097/hjh.0b013e3283656b54 · Cited by 69
Pharmacology and Pathophysiology of Mutated KCNJ5 Found in Adrenal Aldosterone-Producing Adenomas
Tauber, P., Pentón, D., Stindl, J., Humberg, E., Tegtmeier, I., Sterner, C. W., Beuschlein, F., Reincke, M., Barhanin, J., Bandulik, S., et al. (2014) · Endocrinology · doi:10.1210/en.2013-1944 · Cited by 70
Pimenta, E., Stowasser, M., Gordon, R. D., Harding, S. M., Batlouni, M., Zhang, B., Oparil, S., & Calhoun, D. A. (2013) · Chest · doi:10.1378/chest.12-0802 · Cited by 69
Self-citationChanges in the Perceived Epidemiology of Primary Hyperaldosteronism
Fagugli, R. M., & Taglioni, C. (2011) · International Journal of Hypertension · doi:10.4061/2011/162804 · Cited by 72
An update on novel mechanisms of primary aldosteronism
Zennaro, M., Boulkroun, S., & Fernandes-Rosa, F. L. (2014) · Journal of Endocrinology · doi:10.1530/joe-14-0597 · Cited by 69
Haase, M., Riester, A., Kröpil, P., Hahner, S., Degenhart, C., Willenberg, H. S., & Reincke, M. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2788 · Cited by 69
Ladurner, R., Sommerey, S., Buechner, S., Dietz, A., Degenhart, C., Hallfeldt, K. K. J., & Gallwas, J. K. S. (2017) · European Journal of Clinical Investigation · doi:10.1111/eci.12746 · Cited by 69
The prevalence of metabolic syndrome and its components in two main types of primary aldosteronism
Šomlóová, Z., Widimský, J., Rosa, J., Wichterle, D., Štrauch, B., Petrák, O., Zelinka, T., Vlková, J., Mašek, M., Dvořáková, J., et al. (2010) · Journal of Human Hypertension · doi:10.1038/jhh.2010.65 · Cited by 68
The Spectrum of Dysregulated Aldosterone Production: An International Human Physiology Study
Parksook, W. W., Brown, J. M., Omata, K., Tezuka, Y., Ono, Y., Satoh, F., Tsai, L. C., Niebuhr, Y., Milks, J., Moore, A., et al. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae145 · Cited by 69
Different Somatic Mutations in Multinodular Adrenals With Aldosterone-Producing Adenoma
Fernandes-Rosa, F. L., Giscos-Douriez, I., Amar, L., Gómez-Sánchez, C. E., Méatchi, T., Boulkroun, S., & Zennaro, M. (2015) · Hypertension · doi:10.1161/hypertensionaha.115.05993 · Cited by 70
Effect of Spironolactone in Resistant Arterial Hypertension
Václavík, J., Sedlák, R., Jarkovský, J., Kociánová, E., & Táborský, M. (2014) · Medicine · doi:10.1097/md.0000000000000162 · Cited by 66
Diagnostic approach to low‐renin hypertension
Monticone, S., Losano, I., Tetti, M., Buffolo, F., Veglio, F., & Mulatero, P. (2018) · Clinical Endocrinology · doi:10.1111/cen.13741 · Cited by 66
Gao, Y., Ding, J., Cui, Y., Li, T., Sun, H., Zhao, D., Zhang, Y., Huo, L., & Tong, A. (2022) · European Radiology · doi:10.1007/s00330-022-09058-x · Cited by 66
Rossi, G. P., Barisa, M., Belfiore, A., Desideri, G., Ferri, C., Letizia, C., Maccario, M., Morganti, A., Palumbo, G., Patalano, A., et al. (2010) · Journal of Hypertension · doi:10.1097/hjh.0b013e32833d2192 · Cited by 66
Self-citationPrevalence and Diagnosis of Primary Aldosteronism
Rossi, G. P. (2010) · Current Hypertension Reports · doi:10.1007/s11906-010-0134-2 · Cited by 66
Kahn, S. L., & Angle, J. F. (2010) · Techniques in vascular and interventional radiology · doi:10.1053/j.tvir.2010.02.006 · Cited by 66
Acelajado, M. C., & Calhoun, D. A. (2010) · Cardiology Clinics · doi:10.1016/j.ccl.2010.07.002 · Cited by 70
Wang, B., Li, X., Zhang, X., Ma, X., Chen, L., Zhang, Y., Lyu, X., Tang, Y., Huang, Q., Gao, Y., et al. (2015) · Medicine · doi:10.1097/md.0000000000000708 · Cited by 66
Lorenz, K., Langer, P., Niederle, B., Alesina, P. F., Holzer, K., Nies, C., Musholt, T., Goretzki, P. E., Rayes, N., Quinkler, M. O., et al. (2019) · Langenbeck s Archives of Surgery · doi:10.1007/s00423-019-01768-z · Cited by 66
Aldosterone and cardiovascular disease: the heart of the matter
He, B. J., & Anderson, M. E. (2012) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2012.09.004 · Cited by 66
Murthy, M., Xu, S., Massimo, G., Wolley, M. J., Gordon, R. D., Stowasser, M., & O’Shaughnessy, K. M. (2014) · Hypertension · doi:10.1161/hypertensionaha.113.02234 · Cited by 65
Self-citationGlucocorticoid-remediable Aldosteronism
Halperin, F., & Dluhy, R. G. (2011) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2011.01.012 · Cited by 64
Seccia, T. M., D, D. M. M., Battistel, M., Motta, R., Barisa, M., Maniero, C., Pessina, A. C., & Rossi, G. P. (2012) · European Journal of Endocrinology · doi:10.1530/eje-11-0972 · Cited by 64
Adrenal vein sampling for Primary Aldosteronism: time for a reality check
Stewart, P. M., & Allolio, B. (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2009.03714.x · Cited by 63
Wu, V., Hu, Y.-H., Wu, C., Kao, C., Wang, C., Yang, W.-S., Lee, H., Chang, Y.-S., Lin, Y., Wang, S., et al. (2014) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2014.05.012 · Cited by 63
Lubitz, C. C., Economopoulos, K. P., Sy, S., Johanson, C., Kunzel, H. E., Reincke, M., Gazelle, G. S., Weinstein, M. C., & Gaziano, T. A. (2015) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.115.002002 · Cited by 63
Nishimoto, K., Koga, M., Seki, T., Oki, K., Gómez-Sánchez, E. P., Gómez-Sánchez, C. E., Naruse, M., Sakaguchi, T., Morita, S., Kosaka, T., et al. (2016) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.10.014 · Cited by 62
Elliott, W. J. (2009) · Yearbook of Cardiology · doi:10.1016/s0145-4145(08)79419-x · Cited by 62
Stigliano, A., Chiodini, I., Giordano, R., Faggiano, A., Canu, L., Casa, S. D., Loli, P., Luconi, M., Mantero, F., & Terzolo, M. (2015) · Journal of Endocrinological Investigation · doi:10.1007/s40618-015-0349-9 · Cited by 61
Self-citationMineralocorticoid Antagonists Treatment Versus Surgery in Primary Aldosteronism
Catena, C., Colussi, G., Fabio, A. D., Valeri, M., Marzano, L. A., Uzzau, A., & Sechi, L. A. (2010) · Hormone and Metabolic Research · doi:10.1055/s-0029-1246185 · Cited by 60
Outcome of surgical treatment of primary aldosteronism
Citton, M., Viel, G., Rossi, G. P., Mantero, F., Nitti, D., & Iacobone, M. (2015) · Langenbeck s Archives of Surgery · doi:10.1007/s00423-014-1269-4 · Cited by 61
Self-citationConcurrent primary aldosteronism and subclinical cortisol hypersecretion
Fallo, F., Bertello, C., Tizzani, D., Fassina, A., Boulkroun, S., Sonino, N., Monticone, S., Viola, A., Veglio, F., & Mulatero, P. (2011) · Journal of Hypertension · doi:10.1097/hjh.0b013e32834937f3 · Cited by 61
de Rita, O., Hackam, D. G., & Spence, J. D. (2012) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2012.04.014 · Cited by 60
Aldosterone and the Risk of Hypertension
Xanthakis, V., & Vasan, R. S. (2013) · Current Hypertension Reports · doi:10.1007/s11906-013-0330-y · Cited by 60
Influence of Diagnostic Criteria on the Interpretation of Adrenal Vein Sampling
Lethielleux, G., Amar, L., Raynaud, A. C., Plouin, P., & Steichen, O. (2015) · Hypertension · doi:10.1161/hypertensionaha.114.04812 · Cited by 60
Kuo, C., Wu, V., Huang, K., Wang, S.-M., Chang, C., Lu, C., Yang, W., Tsai, C.-W., Lai, C., Lee, T., et al. (2011) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.1177/1470320310391329 · Cited by 60
Positive relationship of sleep apnea to hyperaldosteronism in an ethnically diverse population
Sim, J. J., Yan, E., Liu, I. L. A., Rasgon, S. A., Kalantar‐Zadeh, K., Calhoun, D. A., & Derose, S. F. (2011) · Journal of Hypertension · doi:10.1097/hjh.0b013e3283492219 · Cited by 59
Dorrian, C. A., Toole, B. J., Alvarez‐Madrazo, S., Kelly, A. U., Connell, J. M. C., & Wallace, E. M. (2010) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1258/acb.2010.009230 · Cited by 59
Murata, M., Kitamura, T., Tamada, D., Mukai, K., Kurebayashi, S., Yamamoto, T., Hashimoto, K., Hayashi, R., Kouhara, H., Takeiri, S., et al. (2017) · Journal of Hypertension · doi:10.1097/hjh.0000000000001251 · Cited by 59
Verloop, W. L., Beeftink, M. M. A., Santema, B. T., Bots, M. L., Blankestijn, P. J., Cramer, M. J., Doevendans, P. A., & Voskuil, M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0117332 · Cited by 58
Sonoyama, T., Sone, M., Miyashita, K., Tamura, N., Yamahara, K., Park, K., Oyamada, N., Taura, D., Inuzuka, M., Kojima, K., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0573 · Cited by 58
A subtype prediction score for primary aldosteronism
Nanba, K., Tsuiki, M., Nakao, K., Nanba, A. T., Usui, T., Tagami, T., Hirokawa, Y., Okuno, H. G., Suzuki, T., Shimbo, T., et al. (2014) · Journal of Human Hypertension · doi:10.1038/jhh.2014.20 · Cited by 56
Association of plasma aldosterone with the metabolic syndrome in two German populations
Hannemann, A., Meisinger, C., Bidlingmaier, M., Döring, A., Thorand, B., Heier, M., Belcredi, P., Ladwig, K., Wallaschofski, H., Friedrich, N., et al. (2011) · European Journal of Endocrinology · doi:10.1530/eje-10-1074 · Cited by 57
Functional imaging with 11C-metomidate PET for subtype diagnosis in primary aldosteronism
Soinio, M., Luukkonen, A.-K., Seppänen, M., Kemppainen, J., Seppänen, J., Pienimäki, J., Leijon, H., Vesterinen, T., Arola, J. T., Lantto, E., et al. (2020) · European Journal of Endocrinology · doi:10.1530/eje-20-0532 · Cited by 57
Resistant Hypertension and Aldosterone: An Update
Clark, D., Ahmed, M. I., & Calhoun, D. A. (2012) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2012.03.010 · Cited by 54
Umakoshi, H., Tanase‐Nakao, K., Wada, N., Ichijo, T., Sone, M., Inagaki, N., Katabami, T., Kamemura, K., Matsuda, Y., Fujii, Y., et al. (2015) · Clinical Endocrinology · doi:10.1111/cen.12761 · Cited by 55
Pasternak, J. D., Epelboym, I., Seiser, N., Wingo, M. E., Herman, M. C., Cowan, V., Gosnell, J. E., Shen, W. T., Kerlan, R. K., Lee, J. A., et al. (2015) · Surgery · doi:10.1016/j.surg.2015.06.048 · Cited by 56
Genetics of Aldosterone-Producing Adenoma in Korean Patients
Hong, A. R., Kim, J. H., Song, Y. S., Lee, K. E., Seo, S. H., Seong, M., Shin, C. S., Kim, S. W., & Kim, S. Y. (2016) · PLoS ONE · doi:10.1371/journal.pone.0147590 · Cited by 56
Once and for all, LXRα and LXRβ are gatekeepers of the endocrine system
Maqdasy, S., Trousson, A., Tauveron, I., Volle, D. H., Baron, S., & Lobaccaro, J. A. (2016) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2016.04.001 · Cited by 56
Monticone, S., Bandulik, S., Stindl, J., Zilbermint, M. F., Dedov, I. I., Mulatero, P., Allgäeuer, M., Lee, C. R., Stratakis, C. A., Williams, T. A., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-3636 · Cited by 55
Aldosterone/Renin Ratio Determines Peripheral and Central Blood Pressure Values Over a Broad Range
Tomaschitz, A., Maerz, W., Pilz, S., Ritz, E., Scharnagl, H., Renner, W., Boehm, B. O., Fahrleitner‐Pammer, A., Weihrauch, G., & Dobnig, H. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.01.032 · Cited by 55
Pizzolo, F., Raffaelli, R., Memmo, A., Chiecchi, L., Pavan, C., Guarini, P., Guidi, G. C., Franchi, M. P., Corrocher, R., & Olivieri, O. (2009) · Journal of Hypertension · doi:10.1097/hjh.0b013e32833266e3 · Cited by 55
Kunzel, H. E., Apostolopoulou, K., Pallauf, A., Gerum, S., Merkle, K., Schulz, S., Fischer, E., Brand, V., Bidlingmaier, M., Endres, S., et al. (2012) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2012.08.025 · Cited by 54
Radiofrequency Ablation for Benign Aldosterone-Producing Adenoma
Liu, S. Y., Ng, E. K., Lee, P. S.-F., Wong, S. K., Chiu, P. W. Y., Mui, W. L.-M., So, W.-Y., & Chow, F. C. (2010) · Annals of Surgery · doi:10.1097/sla.0b013e318f66936 · Cited by 55
van der Gugten, J. G., Dubland, J. A., Liu, H., Wang, A. Y., Joseph, C., & Holmes, D. T. (2012) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2011-200564 · Cited by 55
Kerstens, M. N., Kobold, A. C. M., Volmer, M., Koerts, J., Sluiter, W. J., & Dullaart, R. P. F. (2011) · Clinical Chemistry · doi:10.1373/clinchem.2011.165662 · Cited by 55
PRKACA Somatic Mutations Are Rare Findings in Aldosterone-Producing Adenomas
Rhayem, Y., Perez‐Rivas, L. G., Dietz, A., Bathon, K., Gebhard, C., Riester, A., Mauracher, B., Gómez-Sánchez, C. E., Eisenhofer, G., Schwarzmayr, T., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1700 · Cited by 55
The Diagnosis and Treatment of Primary Hyperaldosteronism in Germany
Schirpenbach, C., Segmiller, F. M., Diederich, S., Hahner, S., Lorenz, R. L., Rump, L. C., Seufert, J., Quinkler, M. O., Bidlingmaier, M., Beuschlein, F., et al. (2009) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2009.0305 · Cited by 54
Endocrine Disorders and Cardiovascular Disease
Klein, I. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-0398-6.00086-x · Cited by 87
Somatic and inherited mutations in primary aldosteronism
Fernandes-Rosa, F. L., Boulkroun, S., & Zennaro, M. (2017) · Journal of Molecular Endocrinology · doi:10.1530/jme-17-0035 · Cited by 54
Aldosterone and 18-Oxocortisol Coaccumulation in Aldosterone-Producing Lesions
Sugiura, Y., Takeo, E., Shimma, S., Yokota, M., Higashi, T., Seki, T., Mizuno, Y., Oya, M., Kosaka, T., Omura, M., et al. (2018) · Hypertension · doi:10.1161/hypertensionaha.118.11243 · Cited by 54
Morganti, A. (2010) · Journal of Hypertension · doi:10.1097/hjh.0b013e32833857ad · Cited by 54
Ceral, J., Solař, M., Krajina, A., Ballon, M., Šuba, P., & Cap, J. (2009) · European Journal of Endocrinology · doi:10.1530/eje-09-0217 · Cited by 54
St‐Jean, M., Bourdeau, I., Martin, M., & Lacroix, A. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa703 · Cited by 55
Meunier, C., Blondelle, D., Faure, P., Baguet, J.-P., Goff, C. M. L., Chabre, O., & Ducros, V. (2015) · Clinica Chimica Acta · doi:10.1016/j.cca.2015.05.007 · Cited by 53
Adrenal disorders in pregnancy
Monticone, S., Auchus, R. J., & Rainey, W. E. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2012.155 · Cited by 53
Mebendazole Monotherapy and Long-Term Disease Control in Metastatic Adrenocortical Carcinoma
Dobrosotskaya, I. Y., Hammer, G. D., Schteingart, D. E., Maturen, K. E., & Worden, F. P. (2011) · Endocrine Practice · doi:10.4158/ep10390.cr · Cited by 53
Albiger, N. M., Sartorato, P., Mariniello, B., Iacobone, M., Finco, I., Fassina, A., & Mantero, F. (2011) · European Journal of Endocrinology · doi:10.1530/eje-10-0879 · Cited by 53
Self-citationOno, Y., Nakamura, Y., Maekawa, T., Felizola, S. J. A., Morimoto, R., Iwakura, Y., Kudo, M., Seiji, K., Takase, K., Arai, Y., et al. (2014) · Hypertension · doi:10.1161/hypertensionaha.113.02944 · Cited by 53
An Update on Familial Hyperaldosteronism
Korah, H. E., & Scholl, U. I. (2015) · Hormone and Metabolic Research · doi:10.1055/s-0035-1564166 · Cited by 53
Cardiovascular Risk in Primary Hyperaldosteronism
Warchoł-Celińska, E., Lenders, J. W. M., Januszewicz, A., & Prejbisz, A. (2015) · Hormone and Metabolic Research · doi:10.1055/s-0035-1565124 · Cited by 53
Sarwar, A., Brook, O. R., Vaidya, A., Sacks, A. C., Sacks, B. A., Goldberg, S. N., Ahmed, M., & Faintuch, S. (2016) · Journal of Vascular and Interventional Radiology · doi:10.1016/j.jvir.2016.03.042 · Cited by 53
Treating Primary Aldosteronism-Induced Hypertension: Novel Approaches and Future Outlooks
Mullen, N., Curneen, J. M. G., Donlon, P. T., Prakash, P., Bancos, I., Gurnell, M., & Dennedy, M. C. (2023) · Endocrine Reviews · doi:10.1210/endrev/bnad026 · Cited by 55
Sistema endocrino y corazón: una revisión
Rhee, S. S., & Pearce, E. N. (2011) · Revista Española de Cardiología · doi:10.1016/j.recesp.2010.10.015 · Cited by 52
NovelKCNJ5Mutations in Sporadic Aldosterone-Producing Adenoma Reduce Kir3.4 Membrane Abundance
Cheng, C., Sung, C., Wu, S.-T., Lin, Y.-C., Sytwu, H., Huang, C.-L., & Lin, S. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-3009 · Cited by 52
Cardiac Remodeling in Patients With Primary and Secondary Aldosteronism
Cesari, M., Letizia, C., Angeli, P., Sciomer, S., Rosi, S., & Rossi, G. P. (2016) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.116.004815 · Cited by 52
Inflammation and Fibrosis in Perirenal Adipose Tissue of Patients With Aldosterone-Producing Adenoma
Wu, C., Zhang, H., Zhang, J., Xie, C., Fan, C., Zhang, H., Wu, P., Wei, Q., Tan, W., Xu, L., et al. (2017) · Endocrinology · doi:10.1210/en.2017-00651 · Cited by 51
In situ metabolomics of aldosterone-producing adenomas
Murakami, M., Rhayem, Y., Kunzke, T., Sun, N., Feuchtinger, A., Ludwig, P., Strom, T. M., Gómez-Sánchez, C. E., Knösel, T., Kirchner, T., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.130356 · Cited by 52
Identification of Somatic Mutations in CLCN2 in Aldosterone-Producing Adenomas
Rege, J., Nanba, K., Blinder, A., Plaska, S. W., Udager, A. M., Vats, P., Kumar‐Sinha, C., Giordano, T. J., Rainey, W. E., & Else, T. (2020) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaa123 · Cited by 53
Familial hyperaldosteronism type III
Monticone, S., Tetti, M., Burrello, J., Buffolo, F., Giovanni, R. D., Veglio, F., Williams, T. A., & Mulatero, P. (2017) · Journal of Human Hypertension · doi:10.1038/jhh.2017.34 · Cited by 52
Primary aldosteronism and salt
Funder, J. W. (2014) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-014-1658-0 · Cited by 51
Self-citationUse of Pegvisomant in acromegaly. An Italian Society of Endocrinology guideline
Giustina, A., Ambrosio, M. R., Beck‐Peccoz, P., Bogazzi, F., Cannavò, S., Marinis, L. D., Menis, E. D., Grottoli, S., & Pivonello, R. (2014) · Journal of Endocrinological Investigation · doi:10.1007/s40618-014-0146-x · Cited by 51
Diagnostic Value of ACTH Stimulation Test in Determining the Subtypes of Primary Aldosteronism
Jiang, Y., Zhang, C., Wang, W., Su, T., Zhou, W., Jiang, L., Zhu, W., Xie, J., & Ning, G. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-3551 · Cited by 54
Management of hypertension in primary aldosteronism
Aronova, A., Fahey, T. J., & Zarnegar, R. (2014) · World Journal of Cardiology · doi:10.4330/wjc.v6.i5.227 · Cited by 51
Benham, J. L., Eldoma, M., Khokhar, B. A., Roberts, D. J., Rabi, D. M., & Kline, G. A. (2016) · Journal of Clinical Hypertension · doi:10.1111/jch.12916 · Cited by 51
A Novel Method: Super-selective Adrenal Venous Sampling
Makita, K., Nishimoto, K., Kitamoto, K. K., Karashima, S., Seki, T., Yasuda, M., Matsui, S., Omura, M., & Nishikawa, T. (2017) · Journal of Visualized Experiments · doi:10.3791/55716 · Cited by 51
Prognosis of primary aldosteronism in Japan: results from a nationwide epidemiological study
Miyake, Y., Tanaka, K., Nishikawa, T., Naruse, M., Takayanagi, R., Sasano, H., Takeda, Y., Shibata, H., Sone, M., Satoh, F., et al. (2013) · Endocrine Journal · doi:10.1507/endocrj.ej13-0353 · Cited by 50
Metadata
- Authors
- Funder, J. W., Carey, R. M., Fardella, C., Gomez-Sanchez, C. E., Mantero, F., Stowasser, M., Young, W. F., & Montori, V. M.
- Affiliations
- Prince Henry’s Institute of Medical Research (J.W.F.), Clayton VIC 3168, Australia
- University of Virginia Health System (US)
- Pontificia Universidad Católica de Chile (CL)
- G.V. (Sonny) Montgomery VA Medical Center (C.E.G.-S.), Jackson, Mississippi 39216
- University of Padua (IT)
- The University of Queensland (AU)
- Mayo Clinic (US)
- Mayo Clinic (W.F.Y., V.M.M.), Rochester, Minnesota 55902
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2008-09-01
- Volume
- 93
- Issue
- 9
- Pages
- 3266-3281
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2156903075
- Cited by
- 1,554
- References
- 145
- Citations by year
- 2026: 19 · 2025: 29 · 2024: 34 · 2023: 42 · 2022: 42 · 2021: 51 · 2020: 50 · 2019: 56 · 2018: 70 · 2017: 84 · 2016: 158 · 2015: 182 · 2014: 135 · 2013: 127 · 2012: 169
- FWCI
- 72.82
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Americanae (AECID Library) (submittedVersion, other-oa)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, other-oa)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Keywords
- primary aldosteronism, case finding, aldosterone-renin ratio, confirmatory testing, adrenal computed tomography, unilateral primary aldosteronism, laparoscopic adrenalectomy, bilateral adrenal hyperplasia, mineralocorticoid receptor antagonists, hypertension, hypokalemia
- MeSH terms
- Eplerenone, Mineralocorticoid Receptor Antagonists, Algorithms, Catheterization, Combined Modality Therapy, Cosyntropin, Diagnostic Techniques, Endocrine, Humans, Hyperaldosteronism, Spironolactone, Reproducibility of Results, Hormone Replacement Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
